TimeStamp,Title,Sent,US,Group
2020-04-27T10:58:00,<b>Regeneron</b> and Sanofi's <b>Kevzara</b> shows no clinical benefit in COVID-19 study (NASDAQ:SNY),-1,1,Negative result
2020-03-16T12:09:00,"<b>Regeneron</b>, Sanofi to iniate human trials of treatment for patients with severe COVID-19",1,1,Trial
2020-03-10T20:56:00,Arthritis drug to be tested to treat coronavirus,1,1,Trial
2020-03-03T18:48:00,<b>Regeneron</b> CEO on coronavirus drug timeline,0,1,Other
2020-02-04T09:00:00,Drugmaker <b>Regeneron</b> working with U.S. HHS to develop coronavirus treatment,1,1,Partnership
2019-12-10T14:30:00,"Sanofi, <b>Regeneron</b> to Amend Agreement for <b>Kevzara</b> & Praulent",1,1,Other
